Cargando…

Myocarditis rare after COVID-19 mRNA vaccination

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602511/
http://dx.doi.org/10.1007/s40278-021-05477-5
_version_ 1784601591685316608
collection PubMed
description
format Online
Article
Text
id pubmed-8602511
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-86025112021-11-19 Myocarditis rare after COVID-19 mRNA vaccination Reactions Weekly Clinical Study Springer International Publishing 2021-11-20 2021 /pmc/articles/PMC8602511/ http://dx.doi.org/10.1007/s40278-021-05477-5 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Myocarditis rare after COVID-19 mRNA vaccination
title Myocarditis rare after COVID-19 mRNA vaccination
title_full Myocarditis rare after COVID-19 mRNA vaccination
title_fullStr Myocarditis rare after COVID-19 mRNA vaccination
title_full_unstemmed Myocarditis rare after COVID-19 mRNA vaccination
title_short Myocarditis rare after COVID-19 mRNA vaccination
title_sort myocarditis rare after covid-19 mrna vaccination
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602511/
http://dx.doi.org/10.1007/s40278-021-05477-5